Close this search box.

AbbVie Business Model Canvas

abbVie Business Model Canvas
Photo By abbvie, Edited By Grey Knight

A Brief History of AbbVie

AbbVie Inc. is a pharmaceutical company that was founded in 2013 as a spin-off from the global healthcare company, Abbott Laboratories. The roots of AbbVie can be traced back to Abbott Laboratories, which was founded in 1888 by Dr. Wallace C. Abbott.

AbbVie was established as a separate, independent company with a focus on developing and commercializing advanced therapies for complex and serious diseases. The company has a strong presence in the fields of immunology, oncology, neuroscience, and virology.

Since its founding, AbbVie has grown rapidly through acquisitions and partnerships, expanding its portfolio of products and pipeline of innovative therapies. The company has also invested heavily in research and development to bring new treatments to market and improve patient outcomes.

Today, AbbVie is a global leader in the pharmaceutical industry, with a strong commitment to addressing unmet medical needs and improving the lives of patients around the world. The company continues to innovate and develop new therapies, building on its legacy of excellence in healthcare.

Who Owns AbbVie?

AbbVie Inc. is owned by a wide range of institutional and individual shareholders who hold shares of the company’s stock. The top 10 shareholders of AbbVie Inc. as of the most recent filings include The Vanguard Group, BlackRock Inc., State Street Corporation, Capital International Investors, Fidelity Management & Research Company, Northern Trust Corporation, Morgan Stanley, Geode Capital Management, Wellington Management Company, and Bank of America Corporation. These institutional investors hold significant stakes in the company and contribute to its overall ownership structure. Additionally, there are also numerous individual investors who hold shares of AbbVie Inc. as well.

AbbVie Mission Statement

AbbVie Inc.’s mission statement is to develop and deliver innovative medicines that solve serious health issues and have a remarkable impact on people’s lives. They are focused on discovering, developing, and delivering effective treatments for a range of conditions, including cancer, immunology, neuroscience, and more. AbbVie is dedicated to making a positive impact on patients, partners, and communities through their groundbreaking research and dedication to improving global health outcomes.

How AbbVie Makes Money?

AbbVie Inc. operates a business model focused on pharmaceuticals and biotechnology. The company makes money primarily through the development, manufacturing, and sale of a wide range of drugs and medical products, with a specific emphasis on treatments for conditions such as immunology, oncology, and neuroscience. AbbVie generates revenue through the sales of its prescription medications, as well as through partnerships and collaborations with other healthcare companies. Additionally, the company earns a significant portion of its income through the licensing and royalties associated with its intellectual property and patented technologies.

AbbVie’s Business Model Canvas

The Business Model Canvas is a strategic management tool that allows businesses to describe, design, challenge, invent, and pivot their business model. It consists of nine essential building blocks that help companies to understand their customers, value proposition, revenue streams, key partners, and more. In this article, we will create a detailed Business Model Canvas for AbbVie Inc.

1. Customer Segments:

– AbbVie Inc. primarily targets healthcare providers, physicians, and hospitals as its primary customer segments.
– It also targets patients who are in need of pharmaceutical products and services for various health conditions.

2. Value Propositions:

– AbbVie Inc. provides high-quality, innovative pharmaceutical products and services to improve patient outcomes.
– The company offers personalized healthcare solutions, advanced research and development, and a commitment to improving the health and well-being of patients.

3. Channels:

– AbbVie Inc. distributes its pharmaceutical products through various channels, including healthcare providers, pharmacies, and online platforms.
– The company also utilizes sales reps and marketing efforts to reach its target customer segments.

4. Customer Relationships:

– AbbVie Inc. maintains strong relationships with healthcare providers and hospitals through ongoing communication and support.
– The company also engages with patients through patient support programs and educational resources.

5. Revenue Streams:

– AbbVie Inc. generates revenue through the sale of pharmaceutical products, licensing and royalty fees, and collaboration agreements with other companies.
– The company also earns revenue from the sale of proprietary technologies and intellectual property.

6. Key Resources:

– AbbVie Inc. relies on its research and development capabilities to create innovative pharmaceutical products and solutions.
– The company also leverages its brand reputation, manufacturing facilities, and distribution networks as key resources.

7. Key Activities:

– AbbVie Inc. focuses on pharmaceutical research, clinical trials, regulatory approvals, and commercialization of its products.
– The company also engages in strategic partnerships, acquisitions, and collaborations to expand its portfolio and capabilities.

8. Key Partners:

– AbbVie Inc. collaborates with healthcare providers, academic institutions, research organizations, and industry partners to advance its business goals.
– The company also partners with government agencies, payers, and advocacy groups to enhance patient access and affordability.

9. Cost Structure:

– AbbVie Inc. incurs costs related to research and development, manufacturing, distribution, sales and marketing, and regulatory compliance.
– The company also invests in talent acquisition, intellectual property protection, and ongoing business operations.

AbbVie’s Competitors

AbbVie Inc. operates in the highly competitive pharmaceutical industry, facing significant competition from other major players. Some of its top competitors include: Johnson & Johnson, Pfizer Inc., Merck & Co., Inc., Novartis AG, and Amgen Inc. These companies have a strong presence in the pharmaceutical market and offer a wide range of products and services, making AbbVie’s competitive landscape challenging. Despite the fierce competition, AbbVie Inc. continues to innovate and develop new products to maintain its position in the industry.

AbbVie SWOT Analysis


1. Strong portfolio of pharmaceutical products
2. Leading position in the immunology and oncology market
3. Robust research and development capabilities
4. Established presence in the global market


1. Dependence on a few key products for revenue
2. Limited diversification in its product portfolio
3. Vulnerability to patent expirations
4. High competition in the pharmaceutical industry


1. Expansion into new markets and therapeutic areas
2. Development of innovative drugs and treatments
3. Strategic partnerships and collaborations
4. Emerging markets with growing healthcare needs


1. Regulatory challenges and changes in healthcare policies
2. Increasing pressure to lower drug prices
3. Potential loss of exclusivity for key products
4. Intense competition from generic manufacturers

Concluding Analysis

In conclusion, AbbVie Inc. has demonstrated a strong and resilient business model that has allowed it to thrive in the pharmaceutical industry. With a diverse portfolio of products and a focus on research and development, the company is well-positioned for continued success in the future. As an analyst, I am optimistic about the prospects for AbbVie Inc. and believe that its innovative approach to healthcare will drive growth and value for both the company and its shareholders. In the ever-evolving landscape of the pharmaceutical industry, AbbVie Inc. stands out as a leader, and I look forward to seeing the company’s continued success in the years to come.

Additional Resources

To keep learning and advancing your career, we highly recommend these additional resources:

Business Model Canvas of The Top 1,000 Largest Companies by Market Cap in 2024

A List of 1000 Venture Capital Firms & Investors with LinkedIn Profiles

Peter Thiel and the 16 Unicorns: The Legacy of Thiel Fellowship

9 Biggest IPOs of All Time

List of Fortune 500 Companies in 2023

Receive Daily Startup News

Explore The Pulse of Global Innovation

Delve into the latest news, trends, and insights from startup ecosystems around the world. Stay informed, inspired, and connected to the dynamic landscape of entrepreneurship.

Read by professionals from Y Combinator, AngelPad, 500 Global, and more.

login to your account